Literature DB >> 11819527

Stereoselective propranolol metabolism in two drug induced rat hepatic microsomes.

Xin Li, Su Zeng.   

Abstract

AIM:To study the influence of inducers BNF and PB on the stereoselective metabolism of propranolol in rat hepatic microsomes.
METHODS: Phase I metabolism of propranolol was studied by using the microsomes induced by BNF and PB and the non induced microsome as the control.The enzymatic kinetic parameters of propranolol enantiomers were calculated by regression analysis of Lineweaver-Burk plots. Propranolol concentrations were assayed by HPLC.
RESULTS: A RP-HPLC method was developed to determine propranolol concentration in rat hepatic microsomes. The linearity equations for R(+)propranolol and S(-) propranolol were A = 705.7C+311.2C (R = 0.9987) and a = 697.2C+311.4C (R = 0.9970) respectively. Recoveries of each enantiomer were 98.9%, 99.5%, 101.0% at 60&mgr;mol/L, 120&mgr;mol/L, 240&mgr;mol/L respectively. At the concentration level of 120&mgr;mol/L, propranolol enantiomers were metabolized at different rates in different microsomes. The concentration ratio R(+)/S(-) of control and PB induced microsomes increased with time, whereas that of microsome induced by BNF decreased. The assayed enzyme parameters were: 1. Km. Control group: R(+)30 plus minus 8, S(-)18 plus minus 5; BNF group: R(+)34 plus minus 3, S(-)39 plus minus 7; PB group: R(+)38 plus minus 17, S(-)36 plus minus 10. 2. Vmax. Control group: R(+)1.5 plus minus 0.2, S(-)2.9 plus minus 0.3; BNF group: R(+)3.8 plus minus 0.3, S(-)3.3 plus minus 0.5; PB group: R(+)0.07 plus minus 0.03, S(-)1.94 plus minus 0.07. 3. Clint. Control group: R(+)60 plus minus 3, S(-)170 plus minus 30; BNF group: R(+)111.0 plus minus 1, S(-) 84 plus minus 5; PB group: R(+)2.0 plus minus 2, S(-)56.0 plus minus 1. The enzyme parameters compared with unpaired t tests showed that no stereoselectivity was observed in enzymatic affinity of three microsomes to enantiomers and their catalytic abilities were quite different and had stereoselectivities.Compared with the control, microsome induced by BNF enhanced enzyme activity to propranolol R(+)enantiomer, and microsome induced by PB showed less enzyme activity to propranolol S(-)enantiomer which remains the same stereoselectivities as that of the control.
CONCLUSION: Enzyme activity centers of the microsome were changed in composition and regioselectivity after the induction of BNF and PB, and the stereoselectivities of propranolol cytochrome P450 metabolism in rat hepatic microsomes were likely due to the stereoselectivities of the catalyzing function in enzyme.CYP1A subfamily induced by BNF exhibited pronounced contribution to propranolol metabolism with stereoselectivity to R(+)enantiomer.CYP2B subfamily induced by PB exhibited moderate contribution to propranolol metabolism, but still had the stereoselectivity of S(-)enantiomer.

Entities:  

Year:  2000        PMID: 11819527      PMCID: PMC4723602          DOI: 10.3748/wjg.v6.i1.74

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Propranolol 4- and 5-hydroxylation and N-desisopropylation by cloned human cytochrome P4501A1 and P4501A2.

Authors:  M S Ching; N Bichara; C L Blake; H Ghabrial; R H Tukey; R A Smallwood
Journal:  Drug Metab Dispos       Date:  1996-06       Impact factor: 3.922

2.  Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase.

Authors:  J H Capdevila; A Karara; D J Waxman; M V Martin; J R Falck; F P Guenguerich
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

3.  Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats.

Authors:  S Narimatsu; M Mochida; T Matsumoto; Y Masubuchi; T Horie; K Nagata; Y Funae; A K Cho; T Suzuki
Journal:  Chem Biol Interact       Date:  1996-09-06       Impact factor: 5.192

4.  Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.

Authors:  S V Otton; E M Gillam; M S Lennard; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

5.  Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.

Authors:  K Yoshimoto; H Echizen; K Chiba; M Tani; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

6.  Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen; M Anttila; H Sundqvist
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

Review 7.  Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2.

Authors:  K Brøsen
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

8.  Hepatic cytochrome P450 2B induction by ethyl/phenyl-substituted congeners of phenobarbital in the B6C3F1 mouse.

Authors:  R W Nims; R A Lubet; B A Diwan; D W Mellini; W E Utermahlen; P E Thomas
Journal:  J Biochem Toxicol       Date:  1994-10

9.  Oxidative metabolism of zolpidem by human liver cytochrome P450S.

Authors:  L Pichard; G Gillet; C Bonfils; J Domergue; J P Thénot; P Maurel
Journal:  Drug Metab Dispos       Date:  1995-11       Impact factor: 3.922

10.  The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.

Authors:  N Takahashi; U Harttig; D E Williams; G S Bailey
Journal:  Carcinogenesis       Date:  1996-01       Impact factor: 4.944

View more
  6 in total

1.  Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat.

Authors:  Ken-ichi Umehara; Gian Camenisch
Journal:  Pharm Res       Date:  2011-10-20       Impact factor: 4.200

2.  Stereoselective urinary excretion of S-(-)- and R-(+)-propranolol glucuronide following oral administration of RS-propranolol in Chinese Han subjects.

Authors:  Lian-Jun Luan; Qing Shao; Jian-Yin Ma; Su Zeng
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

3.  Cloning of UGT1A9 cDNA from liver tissues and its expression in CHL cells.

Authors:  X Li; Y N Yu; G J Zhu; Y L Qian
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  Chiral metabolism of propafenone in rat hepatic microsomes treated with two inducers.

Authors:  Q Zhou; T W Yao; S Zeng
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

5.  Development of a New Method Based on Chiral Ligand-Exchange Chromatography for the Enantioseparation of Propranolol.

Authors:  Taher Alizadeh
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

6.  Complete Reaction Phenotyping of Propranolol and 4-Hydroxypropranolol with the 19 Enzymes of the Human UGT1 and UGT2 Families.

Authors:  Fan Yang; Sijie Liu; Gerhard Wolber; Matthias Bureik; Maria Kristina Parr
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.